RenovaCare, Inc. (RCAR)
RenovaCare, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Scottsdale, AZ, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $8,735. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of 0.0%. Its beta of -96.73 implies it has historically moved less than the broad market.
RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. RenovaCare, Inc. has a strategic collaboration StemCell Systems GmbH for isolating and spraying self-donated stem cells to regenerate tissues and organs. The company was formerly known as Janus Resources, Inc. and changed its name RenovaCare, Inc.,to RenovaCare, Inc. in January 2014. RenovaCare, Inc. was incorporated in 1983 and is based in Scottsdale, Arizona.
RenovaCare, Inc. is most often compared with the following Healthcare names: